JP2024531229A5 - - Google Patents

Info

Publication number
JP2024531229A5
JP2024531229A5 JP2024508631A JP2024508631A JP2024531229A5 JP 2024531229 A5 JP2024531229 A5 JP 2024531229A5 JP 2024508631 A JP2024508631 A JP 2024508631A JP 2024508631 A JP2024508631 A JP 2024508631A JP 2024531229 A5 JP2024531229 A5 JP 2024531229A5
Authority
JP
Japan
Prior art keywords
optionally substituted
deuterium
alkyl
compound according
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024531229A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040048 external-priority patent/WO2023018864A1/en
Publication of JP2024531229A publication Critical patent/JP2024531229A/ja
Publication of JP2024531229A5 publication Critical patent/JP2024531229A5/ja
Pending legal-status Critical Current

Links

JP2024508631A 2021-08-12 2022-08-11 幻覚誘発性及び非幻覚誘発性セロトニン受容体アゴニストならびにそれを作製する方法及び使用する方法 Pending JP2024531229A (ja)

Applications Claiming Priority (41)

Application Number Priority Date Filing Date Title
US202163232614P 2021-08-12 2021-08-12
US202163232539P 2021-08-12 2021-08-12
US202163232548P 2021-08-12 2021-08-12
US63/232,548 2021-08-12
US63/232,539 2021-08-12
US63/232,614 2021-08-12
US202163238134P 2021-08-28 2021-08-28
US202163238132P 2021-08-28 2021-08-28
US202163238135P 2021-08-28 2021-08-28
US202163238133P 2021-08-28 2021-08-28
US63/238,135 2021-08-28
US63/238,132 2021-08-28
US63/238,133 2021-08-28
US63/238,134 2021-08-28
US202163239963P 2021-09-02 2021-09-02
US202163239965P 2021-09-02 2021-09-02
US202163239964P 2021-09-02 2021-09-02
US63/239,963 2021-09-02
US63/239,965 2021-09-02
US63/239,964 2021-09-02
US202163285679P 2021-12-03 2021-12-03
US202163285656P 2021-12-03 2021-12-03
US202163285688P 2021-12-03 2021-12-03
US63/285,679 2021-12-03
US63/285,688 2021-12-03
US63/285,656 2021-12-03
US202163292567P 2021-12-22 2021-12-22
US63/292,567 2021-12-22
US202263301196P 2022-01-20 2022-01-20
US63/301,196 2022-01-20
US202263314379P 2022-02-26 2022-02-26
US202263314378P 2022-02-26 2022-02-26
US202263314377P 2022-02-26 2022-02-26
US63/314,379 2022-02-26
US63/314,377 2022-02-26
US63/314,378 2022-02-26
US202263319200P 2022-03-11 2022-03-11
US63/319,200 2022-03-11
US202263325515P 2022-03-30 2022-03-30
US63/325,515 2022-03-30
PCT/US2022/040048 WO2023018864A1 (en) 2021-08-12 2022-08-11 Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2024531229A JP2024531229A (ja) 2024-08-29
JP2024531229A5 true JP2024531229A5 (https=) 2025-08-20

Family

ID=85201052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508631A Pending JP2024531229A (ja) 2021-08-12 2022-08-11 幻覚誘発性及び非幻覚誘発性セロトニン受容体アゴニストならびにそれを作製する方法及び使用する方法

Country Status (8)

Country Link
US (8) US11780807B2 (https=)
EP (1) EP4384172A4 (https=)
JP (1) JP2024531229A (https=)
KR (1) KR20240058859A (https=)
AU (1) AU2022328217A1 (https=)
CA (1) CA3229044A1 (https=)
IL (1) IL310378A (https=)
WO (1) WO2023018864A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3519816A4 (en) 2016-09-29 2020-05-06 The Regents of the University of California CONNECTIONS FOR INCREASING NEURONAL PLASTICITY
KR102946120B1 (ko) 2019-02-27 2026-03-30 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
EP4255422A4 (en) * 2020-12-03 2024-12-18 Mydecine Innovations Group Inc. NEW PSILOCIN ANALOGUE COMPOSITIONS AND METHODS OF THEIR SYNTHESIS
JP2024520485A (ja) * 2021-05-26 2024-05-24 ブライト マインズ バイオサイエンスィズ インコーポレイテッド 複素環式化合物及びその調製方法
KR20240058859A (ko) 2021-08-12 2024-05-03 쿨레온 엘엘씨 환각성 및 비환각성 세로토닌 수용체 작용제 및 이의 제조 및 사용 방법
IL313455A (en) 2021-12-15 2024-08-01 Delix Therapeutics Inc Phenoxy and benzyloxy modified psychroplastogens and their uses
CN118974044A (zh) 2021-12-24 2024-11-15 赛洛私人有限公司 化合物
WO2023173196A1 (en) 2022-03-18 2023-09-21 Enveric Biosciences Canada Inc. C4-carboxylic acid-substituted tryptamine derivatives and methods of using
AU2023234202A1 (en) * 2022-03-18 2024-11-07 Enveric Biosciences Canada Inc. Salts of c4-carboxylic acid- and c4-carbonothioate-substituted tryptamine derivatives and methods of using
WO2024229454A2 (en) * 2023-05-04 2024-11-07 Gilgamesh Pharmaceuticals, Inc. Novel ergolines and methods of treating mood disorders
WO2025000051A1 (en) 2023-06-28 2025-01-02 Psylo Pty Ltd Pyrrolopyridine compounds for the treatment of mental illnesses
WO2025000053A1 (en) 2023-06-28 2025-01-02 Psylo Pty Ltd Compounds
WO2025042885A1 (en) * 2023-08-21 2025-02-27 Kuleon Llc Salts and solid forms of benzothiophene and benzoselenophene serotonin receptor modulators
WO2025049510A1 (en) * 2023-08-29 2025-03-06 Caamtech, Inc. 4-hydroxy-n-ethyltryptamine
WO2025122513A1 (en) * 2023-12-04 2025-06-12 Delix Therapeutics, Inc. Methods of treating neuropsychiatric disorders with non-hallucinogenic tryptamines

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636218A (en) 1969-10-22 1972-01-18 Colgate Palmolive Co Pharmaceutical compositions and methods containing 1 2 3 4-tetrahydrobenzothieno(2 3-c)pyridines
US4137414A (en) 1977-09-26 1979-01-30 G. D. Searle & Co. 5-Substituted-2-phenylbenzo[b]thiophene-3-alkylamines and related compounds
EP0204349A3 (de) 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GB9221761D0 (en) 1992-10-16 1992-12-02 Glaxo Group Ltd Chemical compounds
AU679635B2 (en) 1994-03-11 1997-07-03 Eli Lilly And Company Method for treating 5HT-2B receptor related conditions
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
CA2268164A1 (en) 1996-10-08 1998-04-16 Yao-Chang Xu New serotonin 5-ht1f agonists
HUP0101475A3 (en) * 1998-06-19 2003-01-28 Lundbeck & Co As H 4,5,6 and 7-indole and indoline derivatives, their preparation and use
DE19948417A1 (de) * 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
US7276603B2 (en) * 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
SA05260357B1 (ar) 2004-11-19 2008-09-08 ارينا فارماسيتو تيكالز ، أنك مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
JP5315060B2 (ja) 2006-02-03 2013-10-16 バイオノミックス リミテッド 置換ベンゾフラン、ベンゾチオフェン、ベンゾセレノフェンおよびインドールおよびそれらのチューブリン重合阻害剤としての使用
US20070293475A1 (en) 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
CN103906742A (zh) 2011-09-28 2014-07-02 世宗大学校产学协力团 硒吩稠合芳族化合物和其制备方法
WO2014018888A1 (en) * 2012-07-26 2014-01-30 Confluence Life Sciences Inc. 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as tak1 inhibitors in disease treatment
US10077267B2 (en) 2014-04-04 2018-09-18 Intra-Cellular Therapies, Inc. Organic compounds
EP3519816A4 (en) * 2016-09-29 2020-05-06 The Regents of the University of California CONNECTIONS FOR INCREASING NEURONAL PLASTICITY
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm
CA3052974A1 (en) * 2017-02-09 2018-08-16 CaaMTech, LLC Compositions and methods comprising a psilocybin derivative
KR102946120B1 (ko) 2019-02-27 2026-03-30 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
GB201907871D0 (en) * 2019-06-03 2019-07-17 Small Pharma Ltd Therapeutic compositions
EP4017859A4 (en) 2019-08-25 2023-08-23 Caamtech, LLC ALKYL QUARTERNARY AMMONIUM TRYPTAMINE AND THEIR THERAPEUTIC USES
EP4080407B1 (en) 2019-12-20 2026-02-25 BOE Technology Group Co., Ltd. Inference computing apparatus, model training apparatus, and inference computing system
KR20220137081A (ko) 2020-02-04 2022-10-11 마인드셋 파마 인크. Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 실로신 유도체
EP4165049A4 (en) 2020-06-10 2024-09-11 Delix Therapeutics, Inc. ISOTRYPTAMIN PSYCOPLASTIOGENS AND USES THEREOF
CN119285527A (zh) 2020-06-30 2025-01-10 瑞安神经科学公司 色胺前药
EP4255422A4 (en) 2020-12-03 2024-12-18 Mydecine Innovations Group Inc. NEW PSILOCIN ANALOGUE COMPOSITIONS AND METHODS OF THEIR SYNTHESIS
CN117177959A (zh) 2021-03-18 2023-12-05 赛本爱尔兰有限公司 裸头草碱类似物、盐、组合物和使用方法
JP2024520485A (ja) 2021-05-26 2024-05-24 ブライト マインズ バイオサイエンスィズ インコーポレイテッド 複素環式化合物及びその調製方法
KR20240058859A (ko) 2021-08-12 2024-05-03 쿨레온 엘엘씨 환각성 및 비환각성 세로토닌 수용체 작용제 및 이의 제조 및 사용 방법
WO2023114238A1 (en) 2021-12-15 2023-06-22 Delix Therapeutics, Inc. Aryloxy psychoplastogens and uses thereof
CN118974044A (zh) 2021-12-24 2024-11-15 赛洛私人有限公司 化合物
WO2023219789A1 (en) 2022-05-10 2023-11-16 Mydecine Innovations Group Inc. Novel psilocin prodrug compounds and methods of synthesizing the same
IL318840A (en) * 2022-08-11 2025-04-01 Gilgamesh Pharmaceuticals Inc Tryptamines and methods of treating mood disorders
WO2025042884A2 (en) * 2023-08-21 2025-02-27 Kuleon Llc Serotonin receptor modulators for the treatment of addictions and overdoses
WO2025042885A1 (en) * 2023-08-21 2025-02-27 Kuleon Llc Salts and solid forms of benzothiophene and benzoselenophene serotonin receptor modulators

Similar Documents

Publication Publication Date Title
JP2024531229A5 (https=)
RU2403258C2 (ru) Тиазолилдигидроиндазолы
JP2018511647A5 (https=)
JP2022534426A5 (https=)
JP2019094345A5 (https=)
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
JP2019514874A5 (https=)
JP2016121196A5 (https=)
RU2008150619A (ru) Производные пиразоло{3, 4-d}-пиримидина, применимые для лечения респираторных нарушений
RU2005139398A (ru) Циклические сульфонамиды для ингибирования гамма-секретазы
JP2025500321A5 (https=)
JP2018536648A5 (https=)
CA2470476A1 (en) Pyrrolidine and piperidine derivates as nk1 antagonists
JP2021512109A5 (https=)
KR920018037A (ko) 4-아릴-티아졸 또는 이미다졸 유도체
JP2019527724A5 (https=)
RU2314292C2 (ru) Производные азетидина в качестве антагонистов ccr-3 рецептора
US20170057923A1 (en) Bosutinib Forms and Preparation Methods Thereof
JP2004525183A5 (https=)
MX2025010256A (es) Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno
JP2005526773A5 (https=)
MA29343B1 (fr) Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
JP2021514399A5 (https=)
JP2007500203A5 (https=)
RU2013126219A (ru) Многофункциональные производные нитроксида и их применение